Category: Herbs & Ingredients
Ashwagandha is one of the few adaptogens with a direct, measured effect on thyroid hormones. In a clinical trial it raised T3 and T4 and lowered TSH. That makes the question of combining it with thyroid medication a real one, not a theoretical caution.
Category: Herbs and Ingredients | Reading time: ~13 min | Level: Intermediate
Most supplement interaction warnings are hedged for a reason: the evidence is thin, and the caution is precautionary. This one is different. Ashwagandha does not merely have a theoretical relationship with the thyroid. It has been put into a clinical trial in people with a mild thyroid problem, and it measurably moved their thyroid hormones. That single fact changes the tone of the whole discussion. When a botanical has a demonstrated hormonal effect, combining it with a medication that is dosed against those exact hormones stops being a vague worry and becomes an arithmetic problem.
If you take levothyroxine, or you have an overactive thyroid, or you have been told your thyroid is borderline, this is the interaction to understand before you buy. It is not about scaring you off ashwagandha. It is about making sure that if you use it, you and your prescriber can see what it is doing rather than being surprised by a blood test months later.
One thing to be clear about from the start. The interaction described here is drawn from the published clinical literature and the NIH evidence reviews. It is not a claim manufactured by any single product or platform. The primary study is named below so you can look it up yourself.
Ashwagandha, botanical name Withania somnifera, is an adaptogen best known for stress and sleep. Alongside those effects, it has a less advertised action on the thyroid. In short: the trial evidence available shows ashwagandha raising thyroid hormone levels rather than lowering them. That direction is the whole reason it interacts with thyroid conditions and thyroid medicines the way it does [1][2].
The thyroid runs on a feedback loop. The pituitary releases TSH to tell the thyroid how much hormone to make. The thyroid produces T4 and the more active T3. When thyroid hormone rises, TSH falls, and when it drops, TSH climbs. Thyroid treatment works by nudging this loop into a target range and then holding it there. Anything that independently pushes T3 and T4 up will pull TSH down and shift where that whole system settles [2]. That is the mechanism behind everything in this article.
The study that anchors this is a randomised controlled trial published in 2018 in the Journal of Alternative and Complementary Medicine by Sharma and colleagues [1]. It enrolled 50 adults with subclinical hypothyroidism, an early, mild underactive thyroid state where TSH is raised but the main thyroid hormones are still within range. Participants received a standardised ashwagandha root extract at 600mg per day, or placebo, for eight weeks.
The ashwagandha group showed statistically significant increases in both T3 and T4, alongside a reduction in TSH, compared with placebo [1]. In plain terms, ashwagandha behaved like a mild thyroid stimulant in these participants. For someone with an underactive thyroid, that is a helpful direction of travel. For someone with an overactive thyroid, or someone already taking a calibrated dose of thyroid hormone, it is precisely the wrong direction, or at least a complicating one.
Two honest caveats belong here. First, this is a single, modest trial in a specific population, so the overall evidence grade for ashwagandha as a thyroid agent is limited, not strong. The broader reviewing bodies list thyroid effects among ashwagandha's cautions rather than among its established uses [2]. Second, the participants were not on thyroid medication, so the trial demonstrates that ashwagandha can move thyroid hormones, not exactly how it behaves on top of levothyroxine. The interaction concern is a reasonable inference from a measured effect, and it should be described as such rather than overstated.
The Sharma trial is not the only human dataset pointing this way, which matters because a single study is thin ground for a warning. In a separate placebo-controlled study of ashwagandha in people with bipolar disorder, run for an unrelated reason, the researchers tracked thyroid indices and reported that the ashwagandha-treated participants tended to see their T4 rise from baseline while the placebo group drifted downward [5]. That is a small, secondary observation rather than a thyroid trial in its own right, and the authors were careful to call for properly powered work to confirm it. Still, it is a second human signal in the same upward direction. What remains genuinely unsettled is the mechanism: precisely how ashwagandha nudges thyroid hormone upward has not been well characterised in the literature, so this is best read as a measured effect still waiting for a worked-out explanation, not a closed pharmacological case.
Everything here turns on one fact: ashwagandha appears to push thyroid hormone up, not down. That single direction is why the same ingredient can read as helpful in one setting and risky in another. Thyroid treatment does not aim for higher numbers, it aims for a target range, so even in an underactive thyroid an uncontrolled nudge upward can overshoot. And for anyone on a fixed dose, that dose was calculated on the assumption that nothing else is moving their hormones. Ashwagandha breaks that assumption and drops an unaccounted variable into a system that was carefully balanced. The herb is not toxic to the thyroid; the problem is the loss of control. What that actually means depends on which situation you are in.
If you take levothyroxine. Levothyroxine is a synthetic T4, and its dose is set against your blood tests to hold your TSH in a target band. Ashwagandha appears to raise thyroid hormone independently [1]. Stack the two and you may end up with more thyroid activity than your dose was designed to deliver, which can show up as an out-of-range TSH at your next blood test and, in some people, as symptoms of an overactive thyroid. This does not make the combination forbidden, but it does mean it should only happen with your prescriber informed and your bloods monitored, not discovered after the fact.
If you have an overactive thyroid or Graves disease. This is the strongest caution. Here the body already produces too much thyroid hormone, and the entire aim of treatment is to bring it down. A botanical that pushes it up works against that goal, which is why reviewing bodies advise against ashwagandha in thyroid disorders generally [2]. This is not a monitor-and-see situation; it is a do-not-use-without-specialist-guidance situation.
If you have Hashimoto's or another autoimmune thyroid condition. Two cautions overlap here. Ashwagandha affects thyroid hormones, and it also acts on the immune system, and both are reasons the evidence reviews recommend practitioner oversight in autoimmune conditions [2]. That combination puts Hashimoto's firmly in the discuss-with-your-clinician category.
There is also a separate, more mechanical point worth knowing for anyone taking levothyroxine and any supplement. Levothyroxine absorption is sensitive to what else is in the stomach, and its label advises separating it from other products that can interfere with its absorption by several hours [4]. Even setting the hormonal interaction aside, spacing a morning levothyroxine dose away from other supplements is standard sensible practice.
The practical takeaways are narrow and specific, which is how a real interaction should read.
Do not start ashwagandha on top of thyroid medication, or in a diagnosed thyroid condition, without talking to the prescriber who manages your thyroid. That is the whole headline.
If you and your prescriber decide a trial of ashwagandha is reasonable, agree on monitoring before you begin, because this interaction is invisible to feel and visible only on a blood test. A shift the size seen in the trials is caught far more reliably on TSH, the marker your dose is tuned against, than in how you feel from day to day. A baseline TSH before you start and a repeat a few weeks in, roughly matching the eight-week window over which the trial measured a change, turns an invisible interaction into a number you can act on; some prescribers will also check free T4 [1]. What you are watching for is a TSH drifting below your target range, which would signal more thyroid activity than your dose intends.
Do not adjust your own levothyroxine dose against a supplement. If your levels move, that is a decision for your prescriber, made on the basis of a blood test, not a self-correction against a capsule.
If you stop ashwagandha, tell your prescriber, because your levels may drift back and your medication may need rechecking. The effect is not thought to be permanent; it is active while you take it and tapers afterwards [2].
And if your thyroid status is unknown but you have symptoms that could be thyroid-related, the answer is a blood test and a clinician, not an adaptogen chosen to influence a system you have not yet measured.
This is more monitoring than most supplements warrant, and that is the point. An ingredient with a measured hormonal effect earns a measured approach. If that feels like more effort than a stress supplement is worth to you, that is a perfectly reasonable conclusion, and there are gentler options for stress that do not touch the thyroid at all.
The thyroid interaction is the headline for this article, but ashwagandha carries other cautions that belong in the same decision. The US LiverTox database assigns it a likelihood score indicating it is a probable cause of clinically apparent liver injury, usually within weeks to a few months of starting and generally reversible on stopping, with rare severe cases [3]. It is not recommended in pregnancy or breastfeeding, and it can add to the effect of sedatives [2]. Reviewing bodies list cautions alongside thyroid medicines, immune-suppressing drugs, sedatives, seizure medicines, and blood sugar and blood pressure medicines [2].
Pregnant, breastfeeding, or on medication? Check with a healthcare professional first.
Ashwagandha earns its place in the Remedy Library for stress, where its evidence is moderate, but the thyroid story is exactly why it should never be treated as a casual purchase for someone on medication. The Ashwagandha Stress Tonic is presented with its cautions attached rather than buried, because an interaction like this one is part of the honest picture of the ingredient, not a disclaimer to be tucked away. Structure and function only: ashwagandha supports the body's stress response; it is not a thyroid treatment, and it must not be used to self-manage a thyroid condition.
If you are unsure whether your medication list makes ashwagandha a poor fit, Remy, the PlantRx assistant, can surface the published thyroid and drug cautions relevant to you before you decide, and point you back to your prescriber for the calls that only a blood test can settle.
1. Sharma AK, Basu I, Singh S (2018). Efficacy and safety of ashwagandha root extract in subclinical hypothyroid patients: a double-blind, randomized placebo-controlled trial. Journal of Alternative and Complementary Medicine. RCT, 50 adults with subclinical hypothyroidism, 600mg/day standardised extract, 8 weeks. 2. National Center for Complementary and Integrative Health (NCCIH). Ashwagandha: Usefulness and Safety. Government evidence and safety review. nccih.nih.gov/health/ashwagandha. 3. National Institute of Diabetes and Digestive and Kidney Diseases, LiverTox. Ashwagandha (NBK548536). Government safety monograph. 4. US National Library of Medicine, DailyMed. Levothyroxine sodium (Synthroid) prescribing information. Regulatory drug label, cited for absorption-separation guidance. 5. Gannon JM, Forrest PE, Roy Chengappa KN (2014). Subtle changes in thyroid indices during a placebo-controlled study of an extract of Withania somnifera in persons with bipolar disorder. Journal of Ayurveda and Integrative Medicine. PMID 25624699. Secondary thyroid-index analysis; ashwagandha-treated participants tended to see T4 rise while placebo fell; authors call for adequately powered confirmation.
Not without speaking to the prescriber who manages your thyroid first. Ashwagandha has been shown in a clinical trial to raise thyroid hormone levels, and levothyroxine doses are set precisely against your blood tests. Adding something that nudges those numbers upward can move you out of your target range. This is a timing-and-monitoring conversation, not a flat yes or no.
This is the situation where caution is strongest. In hyperthyroidism and Graves disease the body already makes too much thyroid hormone, and ashwagandha has been shown to push thyroid hormone levels up rather than down. Reviewing bodies advise against use in thyroid disorders for this reason. Do not use it here without specialist guidance.
In the trial evidence available, it raised them. A randomised controlled trial in people with subclinical hypothyroidism found that ashwagandha increased T3 and T4 and lowered TSH over eight weeks. That is a helpful direction for an underactive thyroid but a problematic one for an overactive thyroid or for a levothyroxine dose already tuned to your bloods.
In the trial that measured this, the changes were reported over an eight-week course. That is why monitoring matters: the shift is gradual enough that you would not feel it day to day, but large enough to show up on a blood test and to matter for someone on medication.
Hashimoto's is both a thyroid condition and an autoimmune one, and ashwagandha carries cautions on both counts. Its effect on thyroid hormones and its activity on the immune system are each reasons the reviewing bodies advise practitioner oversight. This is firmly a discuss-with-your-clinician situation rather than a self-managed one.
The effects of ashwagandha are active while you take it and taper after you stop, so its influence on thyroid hormones is not expected to be permanent. The risk is not a lasting change; it is the period of combined use, when your levels may sit higher than your medication dose assumes. Any change to supplements should be shared with your prescriber so bloods can be rechecked.
Stable on medication is exactly the state that a thyroid-raising botanical can disturb, because your dose was set to hold you in range and ashwagandha can shift the target. Even a short course is worth clearing with your prescriber, ideally with a plan to recheck TSH partway through. The cost of asking is a phone call; the cost of not asking is an out-of-range result you cannot explain.
That is not a decision to make from a supplement label, and the trial evidence does not support using ashwagandha as a substitute for prescribed treatment. If your levels moved on ashwagandha, a prescriber might adjust your dose to account for it, but that is a monitored medical decision. Changing your own levothyroxine dose against a supplement is how people end up in the wrong range in both directions.
You mostly would not by feel, which is the point. Thyroid shifts of the size seen in the trial are more reliably caught on a TSH blood test than in symptoms. If you and your prescriber decide a trial of ashwagandha is reasonable, agreeing a blood test before starting and another a few weeks in is the way to actually see what it is doing.